Stockreport

InMed's INM-901 Demonstrates Favorable Pharmacological and Behavioral Effects in In Vivo Preclinical Alzheimer's Disease Studies [Yahoo! Finance]

InMed Pharmaceuticals Inc. - Common Shares  (INM) 
PDF In Vivo studies demonstrate INM-901 reduces neuroinflammation and improves neuronal function Molecular analysis data further explains previously reported observations [Read more]